Brett Fishman

“Just thinking about the quarter and rest of your setup, you know, it seems like you beat pretty nicely versus street and the quarterly guidance on both revenue growth and EPS.”

“Just wanted to start off by asking if you could provide a little bit more color on what you saw in the medical segment this quarter, particularly in Asia and Europe, which seemed a little bit stronger, and then it sounded like North America, the biggest impact was comps, but if there's anything else to call out in…”

“And the longer it goes at that pace, as obvious straight math, it's going to become a bigger element of our overall portfolio don't have a bigger impact on our overall growth so we're pretty excited about it and uh really happy with the integration so far right great and then i'll just ask one more follow-up on the…”

“Just wanted to maybe start off with the robotics segment. And I saw in the press release, you know, you mentioned 7% growth in this category.”

“1Q is generally expected to be the lightest quarter for that segment, and you somewhat exceeded expectations. Do you still see 1Q as being the lightest quarter of the year?”